Abdominal pain, nausea, vomiting, diarrhea, and vertigo have also been reported, and one trial found that the incidence of nausea, vomiting, and vertigo was dose-dependent (77)
These investigations focus on laboratory-based analysis of peptide identity verification, receptor-binding behaviorparticularly interactions with insulin-like growth factor (IGF-1) receptorsmolecular stability profiling, and signaling pathway activity under defined analytical conditions
Animal trials also suggest it may ameliorate models of short-bowel syndrome and speed up the healing
We're not your typical sterile doctor's office
Create an antidepressant effect: According to the National Library of Medicine in a comparative study, BPC-157 can potentially create an antidepressant effect on the brain, promoting similar stress-reduction benefits seen in antidepressant administration